A dynamic structural model for estrogen receptor-α activation by ligands, emphasizing the role of interactions between distant A and E domains

Molecular Cell

Volumn 10, Issue 5, 2002, Pages 1019-1032

  Métivier, Raphaël ^a   Stark, Alexander ^a   Flouriot, Gilles ^b   Hübner, Michael R ^a   Brand, Heike ^a   Penot, Graziella ^a,b   Manu, Dominique ^a   Denger, Stefanie ^a   Reid, George ^a   Koš, Martin ^a   Russell, Robert B ^a   Kah, Olivier ^b   Pakdel, Farzad ^b   Gannon, Frank ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ISOPROTEIN; LIGAND;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; MUTATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; TRANSACTIVATION;

EID: 18744414176     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00746-3     Document Type: Article

References (46)

1. Barton G.J. ALSCRIPT a tool to format multiple sequence alignments. Protein Eng. 6:1993;37-40.
2. Berry M., Metzger D., Chambon P. Role of the two activating domains of the estrogen receptor in the cell-type and promoter-context dependent agonistic activity of the antiestrogen 4-hydroxytamoxifen. EMBO J. 9:1990;2811-2818.
3. Buchner J. Hsp 90 & Co. A holding for folding. Trends Biochem. Sci. 24:1999;136-141.
4. Chen D., Pace P.E., Coombes C., Ali S. Phosphorylation of human estrogen receptor α by protein kinase A regulates dimerization. Mol. Cell. Biol. 19:1999;1002-1015.
5. Cuff J.A., Barton G.J. Application of enhanced multiple sequence alignment profiles to improve protein secondary structure prediction. Proteins. 40:2000;502-511.
6. De Franco D.B. Navigating steroid hormone receptors through the nuclear compartment. Mol. Endocrinol. 16:2002;1449-1455.
7. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
8. Feigelson H.S., Henderson B.E. Estrogens and breast cancer. Carcinogenesis. 17:1996;2279-2284.
9. Flouriot G., Brand H., Denger S., Métivier R., Kos M., Reid G., Sonntag-Buck V., Gannon F. Identification of a new isoform of the human estrogen receptor-α (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J. 19:2000;4688-4700.
10. Freeman B.C., Yamamoto K.R. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science. 296:2002;2232-2235.
11. Green S., Issemann I., Sheer E. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:1988;369.
12. Greenfield N., Vijayanathan V., Thomas T.J., Gall M.A., Thomas T. Increase in the stability and helical content of estrogen receptor α in the presence of the estrogen response element. analysis by circular dichroism spectroscopy Biochemistry. 40:2001;6646-6652.
13. Griffin C., Flouriot G., Sonntag-Buck V., Gannon F. Two functionally different protein isoforms are produced from the chicken estrogen receptor-α gene. Mol. Endocrinol. 13:1999;1571-1587.
14. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736.
15. Hu X., Lazar M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature. 402:1999;93-96.
16. Katzenellenbogen B.S., Sun J., Harrington W.R., Kraichely D.M., Ganessunker D., Katzenellenbogen J.A. Structure-function relationships in estrogen receptors and the characterization of novel selective estrogen receptor modulators with unique pharmacological profiles. Ann. N Y Acad. Sci. 949:2001;6-15.
17. Koš M., Reid G., Denger S., Gannon F. Genomic organization of the human ERα gene promoter region. Mol. Endocrinol. 15:2001;2057-2063.
18. Kraulis P.J. Molscript. a program to produce both detailed and schematic plots of protein structures J. Appl. Crystallogr. 24:1991;946-950.
19. Laudet V. Evolution of the nuclear receptor superfamily. early diversification from an ancestral orphan receptor J. Mol. Endocrinol. 19:1997;207-236.
20. Lavinsky R.M., Jepsen K., Heinzel T., Torchia J., Mullen T.M., Schiff R., Del-Rio A.L., Ricote M., Ngo S., Gemschet al. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. USA. 95:1998;2920-2925.
21. Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A., Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 104:1982;7895-7903.
22. McKenna N.J., O'Malley B.W. Nuclear receptor coactivators-an update. Endocrinology. 143:2002;2461-2465.
23. Métivier R., Petit F.G., Valotaire Y., Pakdel F. Function of N-terminal transactivation domain of estrogen receptor requires a potential α-helical structure and is negatively regulated by the A domain. Mol. Endocrinol. 14:2000;1849-1871.
24. Moras D., Gronemeyer H. The nuclear receptor ligand-binding domain. structure and function Curr. Opin. Cell Biol. 10:1998;384-391.
25. Musgrove E.A., Hamilton J.A., Lee C.S., Sweeney K.J., Watts C.K., Sutherland R.L. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol. 13:1993;3577-3587.
26. Nathan D.F., Vos M.H., Lindquist S. In vivo functions of the Saccharomyces cerevisiæ Hsp90 chaperone. Proc. Natl. Acad. Sci. USA. 94:1997;12949-12956.
27. Nagy L., Kao H.Y., Love J.D., Li C., Banayo E., Gooch J.T., Krishna V., Chatterjee K., Evans R.M., Schwabe J.W. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:1999;3209-3216.
28. Nicholls A., Sharp K., Honig B. Protein folding and association. insights from the interfacial and thermodynamic properties of hydrocarbons Proteins. 11:1991;281-296.
29. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 81:2001;1535-1565.
30. Norris J.D., Fan D., Kerner S.A., McDonnell D.P. Identification of a third autonomous activation domain within the human estrogen receptor. Mol. Endocrinol. 11:1997;747-754.
31. Nuclear Receptor Committee A unified nomenclature system for the nuclear receptor superfamily. Cell. 97:1999;161-163.
32. Pakdel F., Katzenellenbogen B.S. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination. J. Biol. Chem. 267:1992;3429-3437.
33. Pakdel F., Reese J.C., Katzenellenbogen B.S. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor. Mol. Endocrinol. 7:1993;1408-1417.
34. Pakdel F., Métivier R., Flouriot G., Valotaire Y. Two estrogen receptor (ER) isoforms with different estrogen-dependencies are generated from the trout ER gene. Endocrinology. 141:2000;571-580.
35. Russell R.B., Barton G.J. Multiple protein sequence alignment from tertiary structure comparison. Proteins. 14:1992;309-323.
36. Sali A., Blundell T.L. Comparative protein modeling by satisfaction of spatial restraints. J. Mol. Biol. 234:1993;779-815.
37. Shao D., Rangwala S.M., Bailey S.T., Krakow S.L., Reginato M.J., Lazar M.A. Interdomain communication regulating ligand-binding by PPAR-γ Nature. 396:1998;377-380.
38. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103:2000;843-852.
39. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:1998;927-937.
40. Thompson J.D., Higgins D.G., Gibson T.J. Clustal w. improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res. 22:1994;4673-4680.
41. Weigel N.L., Zhang Y. Ligand-independent activation of steroid hormone receptors. J. Mol. Med. 76:1998;469-479.
42. Weis K.E., Ekena K., Thomas J.A., Lazennec G., Katzenellenbogen B.S. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol. Endocrinol. 10:1996;1388-1398.
43. Xu H.E., Stanley T.B., Montana V.G., Lambert M.H., Shearer B.G., Cobb J.E., McKee D.D., Galardi C.M., Plunket K.D., Nolte R.T.et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα Nature. 415:2002;813-817.
44. Yang Z., Hong S.H., Privalsky M.L. Transcriptional anti-repression. J. Biol. Chem. 274:1999;37131-37138.
45. Ylikomi T., Wurtz J.M., Syvala H., Passinen S., Pekki A., Haverinen M., Blauer M., Tuohimaa P., Gronemeyer H. Reappraisal of the role of heat shock proteins as regulators of steroid receptor activity. Crit. Rev. Biochem. Mol. Biol. 33:1998;437-466.
46. Zhuang Y., Katzenellenbogen B.S., Shapiro D.J. Estrogen receptor mutants which do not bind 17β-estradiol dimerize and bind to the estrogen response element in vivo. Mol. Endocrinol. 9:1995;457-466.